Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Liraglutid (ATC-Code nach WHO: A10BJ02; amtlicher ATC: A10BJ02)

The subject of this publication is the conclusion of non-exclusive discount agreements pursuant to § 130a para. 8 SGB V on medicinal products with the active substance Liraglutid (ATC Code according to WHO: A10BJ02; official ATC: A10BJ02). The contract is concluded within the framework of a so-called Open-House model, i.e. a contract conclusion is open to all interested pharmaceutical companies within the participation period, provided that these meet and accept the participation requirements. This means that individual contract negotiations are not conducted and (supply) exclusivity is not given. It is pointed out that the quantity to be procured is unknown, as it depends on demand and the development of the number of insured persons, the prescribing behaviour of doctors and the dispensing and stocking behaviour of public pharmacies. Minimum procurement quantities are therefore not guaranteed. Interested pharmaceutical companies can download the participation documents via the project room of the German Tender Portal (DTVP). For this purpose, an application for access to the project room is required. After the applicant has been released by the contracting authority, the participation documents can be accessed. Absolute secrecy must be maintained regarding the content of the participation documents - in particular regarding the content of the discount agreement and the discounts mentioned therein. Any complete or partial disclosure or provision of content from the participation documents to or for third parties requires the prior written consent of the contracting authority. If participation is waived, all documents must be destroyed immediately in a data protection-compliant manner. The documents to be submitted result from the documents "Cover Letter" and "Explanation of Contract Terms" deposited in the project room. Communication, including the transmission of the participation documents, takes place electronically via the tender portal DTVP; details can be found in the aforementioned documents. Any contrary information in the contract notice is due to technical reasons and does not claim any binding effect. Applications for participation can be submitted for the first time by 4 June 2026. All further submission deadlines can be found in the attachment "Submission Deadlines" deposited in the project room. If the deadline for submission falls on a Saturday, Sunday or a public holiday nationwide, the next working day shall take its place. In the event of late receipt, the submitted applications for participation will be considered for the next submission deadline. The discount agreement ends, regardless of the date of the contract conclusion, at the latest on 30 June 2027. The contracting authority reserves the right to terminate the Open-House procedure prematurely, in particular in the event of concluding exclusive discount agreements; in this case, the discount agreements already concluded end in accordance with the contractual provisions. According to the experience of the contracting authority, exclusive discount agreements usually come into force 8 to 12 months after the publication of the corresponding contract notice in the Supplement to the Official Journal of the European Union.